熱門資訊> 正文

Calidi Biotherapeutics将实施1比10反向股票分割

2024-07-06 04:23

Biotechnology company Calidi Biotherapeutics (NYSE:CLDI) said on Friday that it is set to effect a 1-for-10 reverse stock split, effective 12:01 AM ET on July 15.
CLDI shares were trading -1.83% post-market.
The company's board has approved the reverse stock split, while the stockholders approved the share consolidation plan on June 6.
The new CUSIP number for the shares will be 320703 309.
Source: Press Release

More on Calidi Biotherapeutics

Calidi Biotherapeutics slumps 54%, prices $6.1M equity
Seeking Alpha’s Quant Rating on Calidi Biotherapeutics
Historical earnings data for Calidi Biotherapeutics
Financial information for Calidi Biotherapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。